Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesTo Tell or Not to Tell: The Community Wants to Know About Expensive Anticancer Drugs As a Potential Treatment Option
Journal of Clinical Oncology, 10/06/09
Mileshkin L et al. – Many new cancer treatments are available only at significant financial cost to the patient. The Australian general public wants to be informed about EACD as potential treatment options, even if they are not willing or readily able to pay for them.
Related Articles
Anticancer Chemotherapy Inhibits MHC Class I–Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Cancer Research, 10/21/09
Relevance Score: 65%
Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09
Relevance Score: 65%
Inhibitor of heat shock protein is a potential anticancer drug
EurekAlert, 10/30/09
Relevance Score: 64%
The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09
Relevance Score: 64%
Brain damage from anticancer treatments in adults
Current Opinion in Oncology, 10/13/09
Relevance Score: 64%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Successful Triple Combination Therapy of Disseminated Absidia corymbifera Infection in an Adolescent With Osteosarcoma
Journal of Pediatric Hematology/Oncology, 03/22/10
Successful Treatment of Life-threatening Candida Peritonitis in a Child With Abdominal Non-Hodgkin Lymphoma Using Efungumab and Amphotericin B Colloid Dispersion
Journal of Pediatric Hematology/Oncology, 03/22/10
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer
Cancer Chemotherapy and Pharmacology, 03/22/10
Article Search
Sponsor
Sponsor